{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:48:43Z","timestamp":1789620523447,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1053\/j.seminhematol.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T12:22:40Z","timestamp":1427286160000},"page":"232-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia"],"prefix":"10.1053","volume":"52","author":[{"given":"Christopher G.","family":"Kanakry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos J.","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Luznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1053\/j.seminhematol.2015.03.005_bib1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM198005083021901","article-title":"Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia","volume":"302","author":"Blume","year":"1980","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.03.005_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-102-3-285","article-title":"Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy","volume":"102","author":"Champlin","year":"1985","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"Zittoun","year":"1995","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1053\/j.seminhematol.2015.03.005_bib4","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","article-title":"One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation","volume":"49","author":"Thomas","year":"1977","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"8325","key":"10.1053\/j.seminhematol.2015.03.005_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(83)91793-2","article-title":"Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia","volume":"1","author":"Powles","year":"1983","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.03.005_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","article-title":"Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma","volume":"29","author":"Anasetti","year":"1990","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib10","first-page":"371","article-title":"Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study","volume":"12","author":"Hows","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.03.005_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bmt.1705531","article-title":"Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors","volume":"38","author":"Hows","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM198009043031007","article-title":"Transplantation of marrow from an unrelated donor to a patient with acute leukemia","volume":"303","author":"Hansen","year":"1980","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.03.005_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00007890-199102000-00034","article-title":"Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies","volume":"51","author":"Beatty","year":"1991","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.03.005_bib14","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.1997.15.5.1767","article-title":"Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings","volume":"15","author":"Szydlo","year":"1997","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1053\/j.seminhematol.2015.03.005_bib15","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1182\/blood-2008-07-163212","article-title":"The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation","volume":"113","author":"Ringden","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.03.005_bib16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2013-10-532671","article-title":"Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation","volume":"123","author":"Fernandez-Vina","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.03.005_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V83.1.280.280","article-title":"Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs","volume":"83","author":"Santamaria","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V86.4.1606.bloodjournal8641606","article-title":"The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation","volume":"86","author":"Petersdorf","year":"1995","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.seminhematol.2015.03.005_bib19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJM199810223391701","article-title":"Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program","volume":"339","author":"Sasazuki","year":"1998","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.03.005_bib20","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","article-title":"Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome","volume":"104","author":"Flomenberg","year":"2004","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2015.03.005_bib21","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib22","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/blood.V92.10.3515","article-title":"Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient","volume":"92","author":"Petersdorf","year":"1998","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2015.03.005_bib23","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2013-02-481945","article-title":"Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3\/4\/5 associate with adverse outcomes in hematopoietic stem cell transplantation","volume":"121","author":"Fernandez-Vina","year":"2013","journal-title":"Blood"},{"issue":"16","key":"10.1053\/j.seminhematol.2015.03.005_bib24","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","article-title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","volume":"124","author":"Pidala","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib25","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bmt.1703674","article-title":"Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis","volume":"30","author":"Duggan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1053\/j.seminhematol.2015.03.005_bib26","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","article-title":"Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius","volume":"117","author":"Socie","year":"2011","journal-title":"Blood"},{"issue":"16","key":"10.1053\/j.seminhematol.2015.03.005_bib27","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"issue":"25","key":"10.1053\/j.seminhematol.2015.03.005_bib28","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2014-07-587477","article-title":"Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS","volume":"124","author":"Kanakry","year":"2014","journal-title":"Blood"},{"issue":"32","key":"10.1053\/j.seminhematol.2015.03.005_bib29","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1200\/JCO.2007.15.5184","article-title":"Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group","volume":"26","author":"Schetelig","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.03.005_bib30","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2010-04-278317","article-title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","volume":"116","author":"Gupta","year":"2010","journal-title":"Blood"},{"issue":"30","key":"10.1053\/j.seminhematol.2015.03.005_bib31","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2010.28.6856","article-title":"Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A","volume":"28","author":"Schlenk","year":"2010","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.03.005_bib32","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/leu.2010.102","article-title":"Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission","volume":"24","author":"Walter","year":"2010","journal-title":"Leukemia"},{"issue":"36","key":"10.1053\/j.seminhematol.2015.03.005_bib33","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.03.005_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/TP.0000000000000102","article-title":"Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?","volume":"98","author":"Ringden","year":"2014","journal-title":"Transplantation"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.bbmt.2010.03.024","article-title":"HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category","volume":"16","author":"Woolfrey","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.03.005_bib36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbmt.2013.02.018","article-title":"Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission","volume":"19","author":"Bayraktar","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib37","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1073\/pnas.86.10.3828","article-title":"Human umbilical cord blood as a potential source of transplantable hematopoietic stem\/progenitor cells","volume":"86","author":"Broxmeyer","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1053\/j.seminhematol.2015.03.005_bib38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","article-title":"Outcomes among 562 recipients of placental-blood transplants from unrelated donors","volume":"339","author":"Rubinstein","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.03.005_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3324\/haematol.2013.092254","article-title":"Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France","volume":"99","author":"Labopin","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/leu.2013.259","article-title":"Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT","volume":"28","author":"Ruggeri","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.03.005_bib41","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood-2012-08-449108","article-title":"Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia","volume":"121","author":"Scaradavou","year":"2013","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminhematol.2015.03.005_bib42","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.03.005_bib43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2011.195","article-title":"Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies","volume":"47","author":"Kindwall-Keller","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"22","key":"10.1053\/j.seminhematol.2015.03.005_bib44","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1182\/blood-2010-02-266551","article-title":"Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"116","author":"Mohty","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.03.005_bib45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.bbmt.2011.01.007","article-title":"Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation","volume":"17","author":"Oran","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9577","key":"10.1053\/j.seminhematol.2015.03.005_bib46","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.03.005_bib47","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood-2008-03-147041","article-title":"Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia","volume":"113","author":"Atsuta","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2015.03.005_bib48","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbmt.2007.12.488","article-title":"Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor","volume":"14","author":"Majhail","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1053\/j.seminhematol.2015.03.005_bib49","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1182\/blood-2011-12-400630","article-title":"Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes","volume":"119","author":"Brunstein","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.03.005_bib50","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbmt.2013.06.006","article-title":"Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia","volume":"19","author":"Peffault de Latour","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"10.1053\/j.seminhematol.2015.03.005_bib51","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/bmt.2011.114","article-title":"Reduced-intensity hematopoietic cell transplantation in older patients with AML\/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1053\/j.seminhematol.2015.03.005_bib53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.03.005_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbmt.2011.10.016","article-title":"Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts","volume":"18","author":"Chen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.03.005_bib55","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbmt.2013.03.009","article-title":"Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis","volume":"19","author":"Le Bourgeois","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.03.005_bib56","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbmt.2014.02.020","article-title":"Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a Center for International Blood and Marrow Transplant Research-Eurocord analysis","volume":"20","author":"Weisdorf","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib57","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.bbmt.2014.06.006","article-title":"Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation","volume":"20","author":"Devillier","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"10.1053\/j.seminhematol.2015.03.005_bib58","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1207285","article-title":"Cord-blood engraftment with ex vivo mesenchymal-cell coculture","volume":"367","author":"de Lima","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.03.005_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/bmt.2013.154","article-title":"Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study","volume":"49","author":"Chen","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.03.005_bib60","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.bbmt.2014.08.024","article-title":"Haplo-cord transplantation using CD34 cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders","volume":"20","author":"Kwon","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"10.1053\/j.seminhematol.2015.03.005_bib61","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2015.03.005_bib62","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell-depleted haploidentical \"three-loci\" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.seminhematol.2015.03.005_bib63","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1053\/j.seminhematol.2015.03.005_bib64","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.03.005_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bcmd.2007.07.001","article-title":"Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3\/CD19 depletion and reduced intensity conditioning: an update","volume":"40","author":"Bethge","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib66","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2015.03.005_bib67","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood-2008-02-140095","article-title":"A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation","volume":"112","author":"Ciceri","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2015.03.005_bib68","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2015.03.005_bib69","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.03.005_bib70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbmt.2008.11.025","article-title":"Treatment of acute leukemia with unmanipulated HLA-mismatched\/haploidentical blood and bone marrow transplantation","volume":"15","author":"Huang","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1053\/j.seminhematol.2015.03.005_bib71","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2012-08-453399","article-title":"Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies","volume":"121","author":"Di Bartolomeo","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2015.03.005_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcmd.2009.02.005","article-title":"HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation","volume":"43","author":"Chen","year":"2009","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.03.005_bib73","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbmt.2010.08.023","article-title":"Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison","volume":"17","author":"Wang","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"10.1053\/j.seminhematol.2015.03.005_bib74","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","article-title":"T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT","volume":"124","author":"Luo","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.03.005_bib75","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.seminhematol.2015.03.005_bib76","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol"},{"issue":"211","key":"10.1053\/j.seminhematol.2015.03.005_bib77","doi-asserted-by":"crossref","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","article-title":"Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide","volume":"5","author":"Kanakry","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1053\/j.seminhematol.2015.03.005_bib78","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib79","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"Bashey","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1053\/j.seminhematol.2015.03.005_bib80","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bbmt.2014.05.029","article-title":"Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts","volume":"20","author":"Raiola","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2015.03.005_bib81","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.bbmt.2014.08.013","article-title":"Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10\/10 human leukocyte antigen-matched unrelated and related donors","volume":"20","author":"Di Stasi","year":"2014","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196315000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196315000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:25:17Z","timestamp":1758522317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196315000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0037196315000293"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.03.005","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}